Antidiabetic and antiobesity effects of a highly selective β₃‐adrenoceptor agonist (CL 316,243)

This publication has 16 references indexed in Scilit:

• Anti-obesity and anti-diabetic effects of CL 316, 243, a highly specific β3-adrenoceptor agonist, in yellow KK mice
  Life Sciences, 1994
• Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agent
  Journal of Medicinal Chemistry, 1992
• Radioligand binding studies of the atypical β₃‐adrenergic receptor in rat brown adipose tissue using [³H]CGP 12177
  FEBS Letters, 1992
• Molecular Characterization of the Human β ₃ -Adrenergic Receptor
  Science, 1989
• An investigation of the β-adrenoceptor that mediates metabolic responses to the novel agonist BRL28410 in rat soleus muscle
  Biochemical Pharmacology, 1988
• The rat lipolytic β-adrenoceptor: Studies using novel β-adrenoceptor agonists
  European Journal of Pharmacology, 1984
• Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs
  Nature, 1984
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976
• β-adrenoceptor studoes. III On the β-adrenoceptors in rat adipose tissue
  European Journal of Pharmacology, 1974
• Differentiation of Receptor Systems activated by Sympathomimetic Amines
  Nature, 1967